ARTICLE | Clinical News
Lilly Icos present Phase II data for Cialis
November 28, 2000 8:00 AM UTC
Lilly Icos (Indianapolis, Ind.), a joint venture between Icos (ICOS) and Eli Lilly (LLY), presented data from a 212-patient Phase II trial of Cialis ( IC351), a phosphodiesterase type 5 ( PDE5) inhibi...